Last reviewed: June 18, 2026 Last updated: June 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
doi: 10.1007/s12325-022-02385-x 19 BellidoVAbreu PadnCCatarigAMClarkABarreto PittolSDelgadoE
Aronne LJ, Fujioka K, Aroda V, Chen K, Halseth AE, Kesty NC, et al
Funding S.W.J
Retatrutide is still investigational, so it should not be described as FDA-approved or as having an established safety profile for routine prescribing
Understanding what's driving your hunger, whether it's your dose, timing, food choices, or other factors, is the first step toward finding the right solution